资源描述：
《曲美他嗪联合阿托伐他汀治疗冠心病心绞痛的临床疗效观察》由会员上传分享，免费在线阅读，更多相关内容在应用文档-天天文库。
1、曲美他嗪联合阿托伐他汀治疗冠心病心绞痛的临床疗效观察(德阳第五医院四川德阳618000)目的：探究在冠心病心绞痛的临床治疗屮曲美他嗪和阿托伐他汀的临床应用效果。方法:2015年3月至2015年12月期间，我院心内科接受治疗的冠心病心绞痛患者120例作为研宂对象，根据患者进入我院接受治疗的先后顺序进行分组，其中单号为对照组，双号为观察组，两组患者分别60例，其屮对照组患者采用曲美他嗪进行治疗，观察组患者则结合曲美他嗪和阿托伐他汀进行联合治疗，对比两组患者心功相关指标、血脂、C反应蛋白以及血液流变指标改善情况对应的治疗效果以及不良
2、反应病症发生率。结果：观察组患者的临床治疗有效率98.3°%显著优于对照组85.0%,差异显著符合统计学判断标准(P<0.05),同时观察组患者的不良反应发生率与对照组相比无统计学差异(P>0.05)o结论:在冠心病心绞痛患者的临床治疗屮结合曲美他嗪和阿托伐他汀能够显著改善患者的临床治疗效果，同时降低不良反应发生率，值得在临床上推广应用。【关键词】曲美他嗪；阿托伐他汀；冠心病心绞痛R541A2095-1752(2016)26-0021-02Trimetazidinejointatorvastatintreatmentthecl
3、inicaleffectofthetreatmentofcoronaryheartdiseaseanginapectorisHuangHui.TheFifthHospitalofDeyangCity,SichuanProvince,Deyang618000,China【Abstract】ObjectiveToexploretheclinicaltreatmentofcoronaryheartdiseaseanginapectorisoftrimetazidineandclinicalapplicationeffectofato
4、rvastatin.MethodsDuringMarch2015toDecember2015,ourhospitalheartmedicinefortreatmentof120casesofpatientswithcoronaryheartdiseaseanginaastheresearchobject,accordingtopatientsinourhospitaltreatedinordertogroup,thenumberasthecontrolgroup,doublenumberastheobservationgrou
5、p,twogroupsofpatientswith60casesrespectively,andthecontrolgroupweretreatedbytrimetazidinetreatment,observationgroupofpatientsiscombinedwithtrimetazidinecombinedtreatmentwithatorvastatin,comparedtwogroupsofpatientswithcardiacfunctionrelatedindexes,bloodlipidsandc-rea
6、ctiveproteinandbloodrheologyindexesimprovesituationscorrespondingtreatmenteffectandtheincidenceofadversereactionconditions.ResultsTheobservationgroupofpatientswithclinicalefficient983%significantlybetterthancontrolgroup85.0%significantdifferenceinstatisticalcriterio
7、n(P<0.05),theobservationgroupofpatientsatthesametimetheincidenceofadversereactionscomparedwiththecontrolgroupnosignificantdifference(P>0.05).ConclusionIntheclinicaltreatmentofpatientswithcoronaryheartdiseaseanginapectoriscombinedwithtrimetazidineandatorvastati
8、ncansignificantlyimprovethepatientsclinicalcurativeeffect,atthesametimereducetheincidenceofadversereactions,worthyofpopularizationandappli
